Cancer ResearchMIT nanoparticles turn immune cells into cancer killers inside the body
Cancer immunotherapy may be about to get simpler. MIT scientists have built tiny fat-based particles that deliver genetic instructions straight to natural killer (NK) cells inside the body. The instructions, carried by messenger RNA, teach these cells to make a receptor that finds and destroys harmful T cells, including cancerous ones in lymphoma and misbehaving ones that drive autoimmune hepatitis. Today's CAR T therapies require drawing a patient's blood, engineering the cells in a specialized lab, growing them, and infusing them back, which is slow, costly, and complex. The new approach skips those steps by doing the engineering in the patient. In mouse experiments, the treatment eliminated tumors and reversed liver damage. The work was published in Nature Biotechnology. It is still preclinical, so human benefit is unproven, but it points toward off-the-shelf immune therapies for both cancer and autoimmune disease.